Please note: This trial has finished recruiting and is not accepting new participants.

Research Center: Worldwide Clinical Trials
Location: 2455 NE Loop 410 San Antonio, TX, United States
Lead Doctor: Cynthia A. Zamora, M.D.
IRB Committee: This study has been reviewed and approved by IntegReview Institutional Review Board

Background

 

Struggling with constipation? It is estimated that over 4 million Americans experience chronic constipation. It can be a physical and mental problem that may interfere with daily living. It is expected that there will be an increase in the number of people who will suffer from constipation as it is the most common digestive complaint.

This study seeks to find out the effectiveness of a potential new treatment (SUPREP®) for chronic constipation. SUPREP® is approved by the United States Food and Drug Administration (FDA) for bowel cleansing before receiving a colonoscopy. 

The study seeks men and women aged 18 to 50 years old who have been experiencing constipation for at least 3 months. Participants must experience constipation symptoms at least 6 months before diagnosis. Participants are required to take part in this study for 2 months with a 2-hour screening visit, 1 overnight stay at the research site and 2 follow-up phone calls. Participants may get up to $2,050 for participating in this study. 

Why Participate? 

 

• You may experience relief from chronic constipation.
• You may experience improvements in bowel movement.
• You will be helping to advance medical research.

Your Rights

 

• If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
• Your records relating to this study and any other information received will be kept strictly confidential, except as required by law.
• Qualified health professionals will monitor your health as it relates to the study.

Who Can Participate?

 

• Men and women aged 18 to 50 years old
• Experiencing chronic constipation for at least the past 3 months.
• Able to attend the screening visit and 1 overnight stay at the research site over approximately 2 months.